EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Marine Derived Natural Products: Emerging Therapeutics Against Herpes Simplex Virus Infection

Vaibhav Tiwari iD, James Elste iD, Chunyu Wang, Fuming Zhang iD

Biomolecules · 07.01.2026 · 16 (1) · 100

DOI: 10.3390/biom16010100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.01.2026. Verfasst von Vaibhav Tiwari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, College of Graduate Studies, Midwestern University, Downers Grove, IL 60515, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Biological Products, Herpes Simplex, Aquatic Organisms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex viruses (HSV-1 and HSV-2) are highly prevalent human pathogens that establish lifelong latency in sensory neurons, posing a persistent challenge to global public health. Their clinical manifestations range from mild, self-limiting orolabial lesions to severe, life-threatening conditions such as disseminated neonatal infections, focal encephalitis, and herpetic stromal keratitis, which can lead to irreversible corneal blindness. Beyond direct pathology, HSV-mediated genital ulcerative disease (GUD) significantly enhances mucosal susceptibility to HIV-1 and other sexually transmitted infections, amplifying co-infection risk and disease burden. Despite decades of clinical reliance on nucleoside analogues such as acyclovir, the therapeutic landscape has stagnated with rising antiviral resistance, toxicity associated with prolonged use, and the complete inability of current drugs to eliminate latency or prevent reactivation continue to undermine effective disease control. These persistent gaps underscore an urgent need for next-generation antivirals that operate through fundamentally new mechanisms. Marine ecosystems, the planet’s most chemically diverse environments, are providing an expanding repertoire of antiviral compounds with significant therapeutic promise. Recent discoveries reveal that marine-derived polysaccharides, sulfated glycans, peptides, alkaloids, and microbial metabolites exhibit remarkably potent and multi-targeted anti-HSV activities, disrupting viral attachment, fusion, replication, and egress, while also reshaping host antiviral immunity. Together, these agents showcase mechanisms and scaffolds entirely distinct from existing therapeutics. This review integrates emerging evidence on structural diversity, mechanistic breadth, and translational promise of marine natural products with anti-HSV activity. Collectively, these advances position marine-derived compounds as powerful, untapped scaffolds capable of reshaping the future of HSV therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsBiological ProductsHerpes SimplexAquatic OrganismsSimplexvirusHumansAnimalsHerpesvirus 1, Human

Stichwörter der Autor:innen

HSV entryanti-inflammatoryantiviralherpes simplex virusmarine derived sulfated glycansviral entry inhibitorsvirus host cell interactions

Substanzen

Antiviral AgentsBiological Products

Autor:innen und Institutionen

  • Department of Microbiology & Immunology, College of Graduate Studies, Midwestern University, Downers Grove, IL 60515, USA.
  • Departments of Biological Science, Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
  • Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.

ORCID-Profile: Vaibhav Tiwari, James Elste, Fuming Zhang

Förderung

  • NIA NIH HHS
  • NIH HHS
  • NIH
  • NIH-NIA

Zitieren

APA

Tiwari, V., Elste, J., Wang, C., & Zhang, F. (2026). Marine Derived Natural Products: Emerging Therapeutics Against Herpes Simplex Virus Infection. Biomolecules, 16(1), 100. https://doi.org/10.3390/biom16010100

Vancouver

Tiwari V, Elste J, Wang C, Zhang F. Marine Derived Natural Products: Emerging Therapeutics Against Herpes Simplex Virus Infection. Biomolecules. 2026;16(1):100. doi:10.3390/biom16010100

BibTeX
@article{Tiwari2026,
  author = {Tiwari, Vaibhav and Elste, James and Wang, Chunyu and Zhang, Fuming},
  title = {Marine Derived Natural Products: Emerging Therapeutics Against Herpes Simplex Virus Infection},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {100},
  doi = {10.3390/biom16010100}
}
Kostenlos starten →